Diaphragmatic Pacer Placement: Anesthetic Management (DP)
The Diaphragmatic Pacer (DP) represents a significant advancement in the management of patients with chronic respiratory failure due to SCI and ALS. By potentially reducing reliance on mechanical ventilation, the DP could lead to improved patient quality of life and decreased healthcare costs associated with prolonged mechanical ventilation. The market for respiratory support devices is growing, driven by an increasing prevalence of neuromuscular disorders. Competitive analysis indicates that while there are existing mechanical ventilation solutions, the unique application of diaphragmatic pacing positions the DP as a differentiated offering. Diligence should focus on the long-term efficacy and safety data, as well as reimbursement pathways for the device, which could influence market adoption.
Indication: Spinal Cord Injuries
Modality: medical device
Target: Diaphragmatic pacing via intramuscular electrodes to stimulate diaphragm movement in patients with chronic spinal cord injury (SCI) and Amyotrophic Lateral Sclerosis (ALS).
Sponsor: Institut Guttmann
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 21, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Diaphragmatic pacing via intramuscular electrodes to stimulate diaphragm movement in patients with chronic spinal cord injury (SCI) and Amyotrophic Lateral Sclerosis (ALS).
View original source fields
Condition raw: Spinal Cord Injuries, Amyotrophic Lateral Sclerosis, Respiratory Paralysis
Condition normalized: Spinal Cord Injuries, Amyotrophic Lateral Sclerosis, Respiratory Paralysis
Modality raw: medical device
Modality normalized: medical device
Target raw: Diaphragmatic pacing via intramuscular electrodes to stimulate diaphragm movement in patients with chronic spinal cord injury (SCI) and Amyotrophic Lateral Sclerosis (ALS).
Target normalized: Diaphragmatic pacing via intramuscular electrodes to stimulate diaphragm movement in patients with chronic spinal cord injury (SCI) and Amyotrophic Lateral Sclerosis (ALS).